Of note, low concentrations of HSP90 inhibitors (compared to other such studies) in dual HSF1-HSP90 pathway inhibition were sufficient to strongly impair cell growth in colon-derived tumor organoids and in mice. Here, HSF1 is linked to neoplasm.